| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |